SCHEMBL9628246

SCHEMBL9628246

CCC1=C(OC)C(=O)c2c(Cl)cccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.42
CHRM5 P08912 1/20 0.41
NSD2 O96028 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9642683 0.83 CDC25A (0.57) AR
SCHEMBL9627624 0.83 CDC25A (0.41)
SCHEMBL9628681 0.82 NSD2 (0.42) ARNSD2
SCHEMBL9629324 0.81 MAPT (0.39)
SCHEMBL9642606 0.79 L3MBTL1 (0.43) ARNSD2
SCHEMBL9628254 0.78 MAPT (0.65) NSD2
SCHEMBL9643116 0.76 TP53 (0.41) ARNSD2
SCHEMBL9641783 0.76 ELANE (0.46) ARNSD2
SCHEMBL9642416 0.74 PTPN1 (0.50) NSD2
SCHEMBL125609 0.73 NSD2 (0.55) NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed